The Valencian Ascires sells to the multinational Synlab her genomic business

The Valencian company specialized in the field of Ascires health has closed the sale of its genomic business to the German multinational Synlab, which will become the owner of a laboratory specialized in genetics and bioinformatics of the city of Valencia in which a hundred of people.

The value of the acquisition of the division baptized as genomic systems has not transcended but is part of the Ascires plan to specialize in the clinical and welfare field.A strategy initiated in twenty18 implementing and consolidating the network of eight biomedical clinics, as well as its future hospital in the capital of the Community, which is expected to be ready within two years.

The firm follows from its genetic laboratory division to focus on biomedical artificial intelligence.According to Ascires, the sale does not imply that this business is stopped but that the efforts will focus on the most strict field of health.For its part, it is considered that the laboratory can continue to develop its full potential by integrating into Synlab and expanding its work to other fields related to potential.

With planned revenues of approximately twenty million euros in twenty21, genomic systems has become a key actor in the Spanish diagnostic market after two decades of work.In addition, it is pointed out that the great experience of the laboratory in bioinformatics makes it a leader in the digital transformation of the diagnosis.

twenty.000 employees

The acquisition of this division has also been motivated by the Synlab merger and acquisition plan that aims to generate synergies, expand its laboratory network and increase its technological capacity.In total, twenty0 million will be allocated to this work for twenty22.The multinational has a large structure, operates in 36 countries, has a twenty.000 employees and in twentytwenty had a turnover of 2.600 million euros.

Mathieu Floreani, General Director of Synlab, underlines the strategic value of this acquisition: «If we observe the genetic diagnostic market, tests and advice, as well as the digitalization and automation of diagnostic services, they have great growth potential for growth potentialin the future"."Genomic systems is the only international laboratory that is certified to provide analysis and genetic diagnosis services throughout the life cycle of the human being, and are leaders in bioinformatics," he says in a statement.

The CEO of ASCIRES Biomedical Group, Lorena Saus, highlights the strategic foundation of Ascires to focus on precision medicine integrated into clinical and care activities: «Ascires continues to bet on the integration of genomic data with clinical information from the diagnosisBy image and nuclear medicine, a fundamental activity of the group for more than 50 years ».

«Thanks to the extraordinary precision acquired in our long experience, Ascires has become a reference organization in medical specialties such as neurology and cardiology.There is no doubt that the integration of genomic systems in the Synlab Red will be a catalyst for both companies and their excellent professionals, ”says Saus.